The Global Undescended Testicle Market involves surgical procedures to correct undescended testes in male newborns, infants, children or adults. Undescended testes occur when one or both testicles fail to migrate from the abdomen into the scrotum during fetal development. If left untreated, it can lead to infertility or increase the risk of testicular cancer. The surgical techniques include orchiopexy which uses an incision to guide the testes into the scrotum or orchidectomy which surgically removes the undescended testes. Timely diagnosis and treatment plays a crucial role in preserving male fertility.
The Global Undescended Testicle Market Size is estimated to be valued at US$ 4.51 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global Undescended Testicle Market are Ferring Pharmaceuticals, Pfizer, Eli Lilly and Company, Sanofi, Merck Co., Bayer AG, Endo International, AstraZeneca, Johnson Johnson, Takeda Pharmaceutical.
The rising incidence of male infertility due to increasing risk factors such as lifestyle changes, obesity, genetic disorders and testicular malformations is a major factor driving the growth of the Global Undescended Testicle Market. According to the WHO, infertility affects approximately 8-12% of couples globally with male factor contributing nearly 50% of infertility cases.
Technological advancements in minimally invasive surgical procedures such as laparoscopy are gaining popularity over traditional open surgery due to advantages of reduced postoperative pain, shorter hospital stay and quick recovery time. Advanced imaging modalities such as ultrasound and MRI help in accurate diagnosis of intra-abdominal testes thereby improving surgical outcomes.
Market Trends
There is an increasing adoption of ambulatory surgical centers for undescended testicle procedures which is reducing the healthcare costs and burden on hospitals. Growing medical tourism in low cost countries is also assisting the market growth.
Market Opportunities
Developing regions such as Asia Pacific and Latin America represent major growth opportunities for key players due to increasing medical accessibility and rising healthcare expenditures. In addition, new drug formulations to treat cryptorchidism non-surgically could disrupt the market in the long run.
Impact of COVID-19 on Global Undescended Testicle Market Growth
The onset of the COVID-19 pandemic significantly impacted the growth of the global undescended testicle market. During the initial lockdown phases imposed across nations, non-emergency and elective medical procedures were postponed or delayed worldwide to prevent the spread of the virus and prioritize life-saving care for COVID-19 patients burdening the healthcare infrastructure. This led to a decline in the diagnosis and treatment rates for undescended testicle among babies and children. However, with the easing of lockdown restrictions in 2021 and adoption of proper safety protocols, the market is gradually recovering. Teleconsultations also helped in continuity of care to some extent during the peak pandemic phases. Going forward, the market is expected to regain momentum through 2024 backed by increased awareness regarding testicular health and catching up on the backlog of delayed procedures. Manufacturers are also focusing on ensuring uninterrupted supply of essential medicines to address the condition.
Pre-pandemic, North America dominated the market owing to rising awareness levels and accessibility to advanced treatment options in countries like the United States and Canada. However, the Asia Pacific region is poised to be the fastest growing market during the forecast period attributed to growing healthcare expenditures, rapid urbanization and rising medical tourism in developing nations such as India and China. These nations offer cost-effective treatment procedures attracting patients from other regions as well. Population growth and favorable government initiatives to improve public health are also fueling the APAC market growth.
Europe currently accounts for a significant share of the global market value owing to presence of major pharmaceutical companies and availability of state-of-the-art medical facilities for diagnosis and surgical correction of undescended testicle. Countries like Germany, United Kingdom and France are the major revenue generators for the European market. However, geographic expansion of key players and initiatives to spread awareness in underpenetrated areas can help accelerate market revenues across other emerging regions over the coming years.
What Are The Key Data Covered In This Global Undescended Testicle Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Undescended Testicle's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Undescended Testicle and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Undescended Testicle Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Undescended Testicle vendors
FAQ’s
Q.1 What are the main factors influencing the Global Undescended Testicle?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Undescended Testicle companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Undescended Testicle’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
Get more insights on this topic: https://www.pressreleasebulletin.com/global-undescended-testicle-market-trend-and-demand-2/